ARTICLE | Clinical News
Tesetaxel regulatory update
October 25, 2010 7:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Genta's tesetaxel to treat gastric cancer. The oral, semi-synthetic taxane derivative is in Phase II testing for the indication....